论文信息 - Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2. - 字舞流文

Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.

M. Murcko | F. Maltais | P. Charifson | F. Salituro | Yuegang Zhang | Min Jiang | Alice Tsai | Tiansheng Wang | U. Germann | R. Rijnbrand | E. Perola | M. Jacobs | R. Byrn | Christine Memmott | U. Bandarage | Huai Gao | Y. Bennani | C. Bral | M. P. Clark | W. Gu | J. Duffy | M. Ledeboer | M. Boyd | J. Leeman | J. Court | A. Nezami | Jianglin Liang | W. Dorsch | Ioana Davies | Hamilton B. Bennett | B. Ledford | L. Farmer | J. Kennedy | Colleen F. McNeil | K. Nti-Addae | S. Jones | Randy S. Bethiel | Hongbo Deng | M. Wannamaker | Dylan Jacobs | William P. Taylor | Katrina L Jackson